Methylmalonic acidemias: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:Methylmalonic_acid.svg|thumb| | {{SI}} | ||
{{Infobox medical condition | |||
| name = Methylmalonic acidemias | |||
| image = [[File:Methylmalonic_acid.svg|left|thumb|Methylmalonic acid structure]] | |||
| caption = Structure of methylmalonic acid | |||
| synonyms = MMA | |||
| pronounce = | |||
| specialty = [[Medical genetics]], [[Metabolism]] | |||
| symptoms = [[Developmental delay]], [[lethargy]], [[vomiting]], [[failure to thrive]] | |||
| onset = [[Infancy]] | |||
| duration = [[Chronic]] | |||
| types = [[Methylmalonyl-CoA mutase deficiency]], [[Cobalamin metabolism disorders]] | |||
| causes = [[Genetic mutation]] | |||
| risks = [[Family history]] | |||
| diagnosis = [[Blood test]], [[Urine organic acid test]], [[Genetic testing]] | |||
| differential = [[Propionic acidemia]], [[Isovaleric acidemia]] | |||
| prevention = [[Genetic counseling]] | |||
| treatment = [[Vitamin B12 supplementation]], [[Low-protein diet]], [[L-carnitine]] | |||
| medication = [[Hydroxocobalamin]], [[Cyanocobalamin]] | |||
| prognosis = Variable, depends on type and treatment | |||
| frequency = 1 in 50,000 to 100,000 | |||
| deaths = | |||
}} | |||
Methylmalonic acidemias are a group of inherited metabolic disorders characterized by the body's inability to break down certain proteins and fats. This results in the accumulation of [[methylmalonic acid]] in the blood and tissues, leading to a variety of symptoms and complications. | Methylmalonic acidemias are a group of inherited metabolic disorders characterized by the body's inability to break down certain proteins and fats. This results in the accumulation of [[methylmalonic acid]] in the blood and tissues, leading to a variety of symptoms and complications. | ||
== Signs and Symptoms == | == Signs and Symptoms == | ||
Symptoms of methylmalonic acidemias can vary widely depending on the specific type and severity of the condition. Common symptoms may include [[vomiting]], [[lethargy]], [[weakness]], [[hypotonia]], and developmental delays. In severe cases, affected individuals may experience metabolic crises, which can be life-threatening if not promptly treated. | Symptoms of methylmalonic acidemias can vary widely depending on the specific type and severity of the condition. Common symptoms may include [[vomiting]], [[lethargy]], [[weakness]], [[hypotonia]], and developmental delays. In severe cases, affected individuals may experience metabolic crises, which can be life-threatening if not promptly treated. | ||
== Causes == | == Causes == | ||
Methylmalonic acidemias are caused by mutations in genes that are involved in the breakdown of certain amino acids and fats. These genetic mutations result in a deficiency of enzymes needed to metabolize these substances, leading to the accumulation of methylmalonic acid in the body. | Methylmalonic acidemias are caused by mutations in genes that are involved in the breakdown of certain amino acids and fats. These genetic mutations result in a deficiency of enzymes needed to metabolize these substances, leading to the accumulation of methylmalonic acid in the body. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of methylmalonic acidemias typically involves a combination of clinical evaluation, biochemical testing, and genetic testing. Elevated levels of methylmalonic acid in the blood or urine can be indicative of the condition. Genetic testing can confirm the diagnosis and identify the specific genetic mutations responsible for the disorder. | Diagnosis of methylmalonic acidemias typically involves a combination of clinical evaluation, biochemical testing, and genetic testing. Elevated levels of methylmalonic acid in the blood or urine can be indicative of the condition. Genetic testing can confirm the diagnosis and identify the specific genetic mutations responsible for the disorder. | ||
== Treatment == | == Treatment == | ||
Treatment for methylmalonic acidemias is aimed at managing symptoms and preventing metabolic crises. This may involve dietary restrictions, supplementation with specific nutrients, and in some cases, organ transplantation. Early detection and intervention are crucial in improving outcomes for individuals with this condition. | Treatment for methylmalonic acidemias is aimed at managing symptoms and preventing metabolic crises. This may involve dietary restrictions, supplementation with specific nutrients, and in some cases, organ transplantation. Early detection and intervention are crucial in improving outcomes for individuals with this condition. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with methylmalonic acidemias can vary depending on the type and severity of the condition. With proper management and treatment, some individuals can lead relatively normal lives. However, severe forms of the disorder can be life-threatening and may require ongoing medical care. | The prognosis for individuals with methylmalonic acidemias can vary depending on the type and severity of the condition. With proper management and treatment, some individuals can lead relatively normal lives. However, severe forms of the disorder can be life-threatening and may require ongoing medical care. | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Metabolic disorders]] | [[Category:Metabolic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
Latest revision as of 03:52, 8 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Methylmalonic acidemias | |
|---|---|
| Synonyms | MMA |
| Pronounce | |
| Specialty | Medical genetics, Metabolism |
| Symptoms | Developmental delay, lethargy, vomiting, failure to thrive |
| Complications | N/A |
| Onset | Infancy |
| Duration | Chronic |
| Types | Methylmalonyl-CoA mutase deficiency, Cobalamin metabolism disorders |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Blood test, Urine organic acid test, Genetic testing |
| Differential diagnosis | Propionic acidemia, Isovaleric acidemia |
| Prevention | Genetic counseling |
| Treatment | Vitamin B12 supplementation, Low-protein diet, L-carnitine |
| Medication | Hydroxocobalamin, Cyanocobalamin |
| Prognosis | Variable, depends on type and treatment |
| Frequency | 1 in 50,000 to 100,000 |
| Deaths | |
Methylmalonic acidemias are a group of inherited metabolic disorders characterized by the body's inability to break down certain proteins and fats. This results in the accumulation of methylmalonic acid in the blood and tissues, leading to a variety of symptoms and complications.
Signs and Symptoms[edit]
Symptoms of methylmalonic acidemias can vary widely depending on the specific type and severity of the condition. Common symptoms may include vomiting, lethargy, weakness, hypotonia, and developmental delays. In severe cases, affected individuals may experience metabolic crises, which can be life-threatening if not promptly treated.
Causes[edit]
Methylmalonic acidemias are caused by mutations in genes that are involved in the breakdown of certain amino acids and fats. These genetic mutations result in a deficiency of enzymes needed to metabolize these substances, leading to the accumulation of methylmalonic acid in the body.
Diagnosis[edit]
Diagnosis of methylmalonic acidemias typically involves a combination of clinical evaluation, biochemical testing, and genetic testing. Elevated levels of methylmalonic acid in the blood or urine can be indicative of the condition. Genetic testing can confirm the diagnosis and identify the specific genetic mutations responsible for the disorder.
Treatment[edit]
Treatment for methylmalonic acidemias is aimed at managing symptoms and preventing metabolic crises. This may involve dietary restrictions, supplementation with specific nutrients, and in some cases, organ transplantation. Early detection and intervention are crucial in improving outcomes for individuals with this condition.
Prognosis[edit]
The prognosis for individuals with methylmalonic acidemias can vary depending on the type and severity of the condition. With proper management and treatment, some individuals can lead relatively normal lives. However, severe forms of the disorder can be life-threatening and may require ongoing medical care.

